FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of general formula
(I), compositions including the compounds.
EFFECT: compounds for treatment of diabetes, metabolic syndrome and obesity (HSL-inhibitors).
15 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,8-DIAZASPIRO[4,5]DECAN-1-ONE DERIVATIVES, USEFUL AS INHIBITORS OF HORMONE-SENSITIVE LIPASE (HSL) | 2011 |
|
RU2606513C2 |
| NEW AZACYCLIC COMPOUNDS | 2011 |
|
RU2603263C2 |
| SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF HSL, EFFECTIVE FOR DIABETES TREATMENT | 2010 |
|
RU2607080C2 |
| AZACYCLIC SPIRO-COMPOUNDS | 2010 |
|
RU2550495C2 |
| HETEROCYCLIC COMPOUNDS | 2019 |
|
RU2809257C2 |
| HYDANTOIN DERIVATIVE | 2013 |
|
RU2678984C2 |
| DIAZASPIROPIPERIDINE DERIVATIVES | 2004 |
|
RU2355690C2 |
| DIAZASPIROPIPERIDINE DERIVATIVES AS GLYCINE CARRIER 1 AND GLYCINE CARRIER 2 INHIBITORS | 2004 |
|
RU2351599C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HYDANTOIN DERIVATIVES | 2014 |
|
RU2701168C2 |
| MUSCARINIC RECEPTOR AGONISTS | 2015 |
|
RU2678835C2 |
Authors
Dates
2015-11-10—Published
2011-04-12—Filed